To screen ETFs by asset class, performance, yield and more, check out the
FDA approves new use for Eylea. More upside to Regeneron $
Add a reply...
Latest StockTalks »
people get REGN breaking news and analysis by email alert.
Get email alerts on REGN »
Regeneron Pharmaceuticals, Inc.
Get latest price
From other sites
Biotech Stock Roundup: Shire to Acquire NPSP, Celgene & Pharmacyclics Give Strong Outlook - Analyst Blog
at Zacks.com (Jan 14, 2015)
Aegerion Reveals Preliminary 2014 Results and 2015 Outlook - Analyst Blog
at Zacks.com (Jan 13, 2015)
Regeneron/Sanofi Seek PCSK9 Drug Praluent Approval in EU - Analyst Blog
at Zacks.com (Jan 12, 2015)
Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2
at Benzinga.com (Jan 12, 2015)
Nasdaq 100 Movers: SNDK, CELG
at Nasdaq.com (Jan 12, 2015)
Xignite quote data
© 2015 Seeking Alpha